WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 3'1601 Infant (under 12 months) mortality rate: 262
GDP / capita (US$): 5'4621 Child (under 5 years) mortality rate: 312

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 2'796  2'754  2'713  2'672  2'633  2'397  2'184  1'690 
Births 64  63  62  61  59  46  69  66 
Surviving infants 62  62  61  59  57  44  64  59 
Pop. less than 5 years 306  297  280  268  254  234  332  275 
Pop. less than 15 years 760  746  731  724  719  834  884  738 
Female 15-49 years 826  822  817  809  799  656  527  370 

Number of reported case

(Click for retrospective incidence data for Mongolia)
Diphtheria
Japanese encephalitis
Measles 31  925  296  5'338 
Mumps 9'060  1'016  524  1'990  560  874 
Pertussis 22 
Polio*
Rubella 240  13  11  167  1'550 
Rubella (CRS)
Tetanus (neonatal)
Tetanus (total)
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mongolia)
Vaccine year result method % card seen                                                
BCG 2009  98  MICS   85.0  99  99  99  98  98  97 
DTP1 2009  96  MICS   85.0  100  99  98  95  98  95 
DTP3 2009  92  MICS   85.0  100  99  96  95  96  95 
HepB_BD          97  96  95  98  94  96 
HepB3          100  99  96  97  96  93 
Hib3          100  99  96  97  96 
JapEnc         
MCV 2009  88  MICS   85.0  99  98  97  94  97  92 
MCV2          98  98  95  97  96  75 
PCV1         
PCV3         
Pol3 2009  94  MICS   85.0  100  99  96  96  95  94 
Rota1         
Rota_last         
Rubella1          99  98  97 
TT2plus         
PAB         
VAD1         
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mongolia)
BCG 99  99  99  98  98  97  81  51 
DTP1 99  99  98  95  98  95  94  91 
DTP3 99  99  96  95  96  94  84  76 
HepB3 99  99  96  97  96  93 
Hib3 99  99  96  97  96 
MCV 99  98  97  94  97  92  92  17 
PCV3
Pol3 99  99  96  96  95  94  87  86 
Rota_last

Number of districts in the country 338  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 99
From 80 to 89% 1
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DT 7, 15 years; Yes
DTwPHibHepB 2, 3, 4 months; Yes
HepA 14 months; 2 years; No
HepB birth; Yes
MMR 9 months: 2 years; Yes
OPV birth; 2, 3, 4 months; Yes

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2008-2012  2008-2012  2007-2012  2007-2012  2'011 
Nº of districts with microplans that include activities to raise immunization coverage number 338  48  71  127  356    NA 

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 338  338  340  338  356  342  342 
Nº districts with DTP3 coverage >=80% number 338  338  339  337  356  325  342 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  95  100 
Nº districts with measles (MCV1) coverage >=95% number 325  323  319  307  329     
% of districts with MCV1 coverage >=95% From 0 to 100% 96  96  94  91  92     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes         

Finance

Percentage of routine vaccines funded by Government From 0 to 100% 75  69  80  64  61  19  NA 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.